Targeted Medical Pharma, Inc. Announces Earnings Results for Second Quarter and Six Months Ended June 30, 2013
For the six months, the company's total revenue was increased 67% to $4,728,519 compared to $2,823,411 in first half of 2012. Furthermore, total gross profit for the quarter increased 97% to $3,094,375 in 2013 compared to $1,567,416 in 2012. The loss from operations decreased 29% to $2,326,320 compared to the loss from operations of $3,268,229 in 2012.